Pharmaceutical Companies
Rapport Therapeutics
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 58
- Market Cap
- $746.1M
- Website
- -
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology...
Liquidia Technologies, Inc.
πΊπΈUnited States
- Ownership
- Public, Subsidiary
- Established
- 2004-01-01
- Employees
- 101
- Market Cap
- $741M
- Website
- http://www.liquidia.com
Mereo BioPharma
π¬π§United Kingdom
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313),...
Exscientia
π¬π§United Kingdom
CureVac SE
π©πͺGermany
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 251
- Market Cap
- $735.7M
- Website
- http://www.curevac.com
Mesoblast
πΊπΈUnited States
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- 73
- Market Cap
- $733.9M
- Website
- http://www.angioblast.com
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders,...
Arbutus Biopharma
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 73
- Market Cap
- $730.5M
- Website
- -
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The...
Stoke Therapeutics
πΊπΈUnited States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 110
- Market Cap
- $730.2M
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver....
Scholar Rock
πΊπΈUnited States
- Ownership
- -
- Established
- -
- Employees
- 150
- Market Cap
- $725M
- Website
- -
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays...
Avalon Pharma (Middle East Pharmaceutical)
πΈπ¦Saudi Arabia
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $721.2M
- Website
- -
